Tactile Systems Technology INC 10-Q quarterly reports

Tactile Systems Technology reported a 23% increase in Q1 2026 revenue to $75.3 million, driven by strong lymphedema and airway clearance product sales, while net loss narrowed to $1.8 million.

Tactile Systems Technology, Inc. reported significant revenue and net income growth for Q3 2025, driven by strong performance in its airway clearance product line and strategic initiatives, while also fully repaying its term loan.

Tactile Systems Technology, Inc. reported an 8% revenue increase in Q2 2025, driven by airway clearance products, but net income declined 25% due to higher operating expenses.

Tactile Systems Technology's Q1 2025 results reveal a slight revenue increase offset by a higher net loss, alongside ongoing legal proceedings and a share repurchase program.

Tactile Systems Technology, Inc. announced a 5% increase in revenue for the third quarter of 2024 compared to the same period last year, alongside a net income of $5.2 million.

Tactile Systems Technology, Inc. reports a 7% increase in revenue and a return to profitability for the second quarter of 2024, driven by growth in its lymphedema product line.

Tactile Systems Technology saw a 4% increase in revenue and a reduced net loss in the first quarter of 2024 compared to the same period last year.